Particularly, we found that E-cadherin undergoes a decreased O-mannosylation in cancer that resulted in the impairment of E-cadherin functions in cancer cells through interfering in its cell membrane localization and in the assembly and competence of adherens junctions. Here, CDH1 is linked to cancer.